Evaluation of Vitrectomy with Planned Foveal Detachment as Surgical Treatment for Refractory Diabetic Macular Edema with or without Vitreomacular Interface Abnormality

Figure 4

(a) Color fundus photo and late FA image of a male 53 years of age with type 2 DM, suffering from refractory DME with VMA with a CMT of 369 microns after 8 IVR injections over the past 9 months. BCVA recorded was 0.2. (b) Diffuse DME shown in a late FA image with CMT of 383 after shifting to IVA for three consecutive injections. (c) Upper snap shot during removal of the fine ERM stained with the dual stain, middle image showing ILM peeling, while the lower photo was taken during submacular BSS injection. (d) Red free with color-coded map showing slight CMT improvement 4 weeks postoperatively reaching 372 microns. (e) Eight months postoperation with edema reaching 335 without additional treatment and BCVA improved to 0.8.

(a)

(b)

(c)

(d)

(e)